PolyPid Ltd. (PYPD)
5.145
+0.04
(+0.88%)
USD |
NASDAQ |
Aug 26, 16:00
5.145
0.00 (0.00%)
After-Hours: 18:09
PolyPid Total Liabilities (Quarterly) : 9.846M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.846M |
| March 31, 2026 | 10.38M |
| December 31, 2025 | 11.33M |
| September 30, 2025 | 11.48M |
| June 30, 2025 | 17.21M |
| March 31, 2025 | 16.76M |
| December 31, 2024 | 17.54M |
| September 30, 2024 | 17.44M |
| June 30, 2024 | 17.93M |
| March 31, 2024 | 18.25M |
| December 31, 2023 | 17.47M |
| September 30, 2023 | 17.39M |
| June 30, 2023 | 17.92M |
| Date | Value |
|---|---|
| March 31, 2023 | 20.29M |
| December 31, 2022 | 20.14M |
| September 30, 2022 | 17.88M |
| June 30, 2022 | 15.71M |
| March 31, 2022 | 6.636M |
| December 31, 2021 | 8.275M |
| September 30, 2021 | 5.336M |
| June 30, 2021 | 4.511M |
| March 31, 2021 | 3.692M |
| December 31, 2020 | 3.07M |
| September 30, 2020 | 1.865M |
| June 30, 2020 | 4.121M |
| March 31, 2020 | 16.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 32.10B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 27.45M |
| Purple Biotech Ltd. | 1.953M |
| Sol-Gel Technologies Ltd. | 5.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.23M |
| Shareholders Equity (Quarterly) | 5.388M |
| Debt to Equity Ratio | 0.2918 |
| Current Ratio | 1.346 |
| Net Debt Paydown Yield | 1.41% |